Alchemab awarded 1.7 million grant to develop Huntington’s disease therapy
Alchemab Therapeutics - 16-Dec-2022New antibody approach aims to slow or halt Huntington’s disease progression
Join the club for FREE to access the whole archive and other member benefits.
Government funded, not-for-profit organisation
Medicines Discovery Catapult is a national Life Sciences service that reshapes drug discovery to deliver better treatments for patients
We partner with innovators across the sector, helping them turn bold scientific ideas into real-world impact.
Our model supports drug discovery companies at every step, from early research through to commercialisation, by providing access to world-class science, laboratories, technologies, and expertise.
We de-risk drug discovery, run collaborative R&D partnerships, and reinvest in our sector to drive growth.
Visit website: https://md.catapult.org.uk/
Details last updated 19-Dec-2020
New antibody approach aims to slow or halt Huntington’s disease progression
Innovate UK is funding specialists of nanotechnology & bioimaging to cure cancer